In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Kymera Therapeutics Inc’s stock clocked out at $46.35, down -1.05% from its previous closing price of $46.84. In other words, the price has decreased by -$1.05 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
To gain a deeper understanding of KYMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.49 and its Current Ratio is at 8.49. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On June 03, 2025, B. Riley Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $60.
BofA Securities Upgraded its Neutral to Buy on June 02, 2025, while the target price for the stock was maintained at $51.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 11 ’25 when Ridloff Elena sold 4,500 shares for $50.00 per share. The transaction valued at 225,000 led to the insider holds 0 shares of the business.
ELENA RIDLOFF bought 4,500 shares of KYMR for $218,700 on Jun 11 ’25. On Jun 03 ’25, another insider, Esposito Pamela, who serves as the Director of the company, sold 5,000 shares for $49.04 each. As a result, the insider received 245,186 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 51.26 while its Price-to-Book (P/B) ratio in mrq is 3.84.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is 38.62%, while the 200-Day Moving Average is calculated to be 17.38%.
Shares Statistics:
A total of 65.11M shares are outstanding, with a floating share count of 53.16M. Insiders hold about 18.37% of the company’s shares, while institutions hold 95.94% stake in the company.
